3rd Quarter - Report

CALIFORNIA LIFE SCIENCES for CALIFORNIA LIFE SCIENCES

Firm
Client
Income
—
Expenses
$160,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Immigration IMM

Support STEM-Ed/H-1B related provisions in any immigration reform measure.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
TODD E GILLENWATER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Trade (domestic/foreign) TRD

Address concerns with India trade/IP policies.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
TODD E GILLENWATER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Support repeal of medical device tax. Support extension of Therapeutic Discovery Tax Credit.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
TODD E GILLENWATER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Address concerns with Medicare Independent Payment Advisory Board (IPAB). Address concerns with changes to Medicare Part B and Part D programs, and 2014 Hospital Outpatient Prospective Payment System.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
TODD E GILLENWATER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Labor/HHS/Ed Appropriations: NIH, biodefense/pandemic, science/math education, and strategic stockpilefunding and preparation; FDA Appropriations; PTO Appropriations. FDA and PTO User Fee sequestration.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
TODD E GILLENWATER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

Support NIH research funding.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
TODD E GILLENWATER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Address concerns regarding uncertainty and unpredictability of FDA drug and device regulatory environment. Address concerns with Medicare Independent Payment Advisory Board (IPAB). Address concerns with changes to Medicare Part B and Part D programs. Support federal Track-and-Trace legislation, including Uniform National Standard.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
TODD E GILLENWATER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.